|
Dose Level 2A: 6 x 10^7 cells/m2 Clinical Trials
1 actively recruiting trial across 1 location
Houston, Texas1 trial
EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma
Houston Methodist Hospital
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.